Atlas Laboratories And Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 20.00 Cr
as on 06-12-2024
- Paid Up Capital ₹ 7.88 Cr
as on 06-12-2024
- Company Age 42 Year, 9 Months
- Last Filing with ROC 31 Mar 2010
- Open Charges ₹ 32.00 Cr
as on 06-12-2024
- Satisfied Charges ₹ 9.00 Cr
as on 06-12-2024
About Atlas Laboratories And Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2010. It's a company limited by shares with an authorized capital of Rs 20.00 Cr and a paid-up capital of Rs 7.88 Cr.
The company currently has active open charges totaling ₹32.00 Cr. The company has closed loans amounting to ₹9.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Salil Kapur, Suresh Gupta, Pradeep Kumar, and One other member serve as directors at the Company.
- CIN/LLPIN
U74899DL1982PLC013227
- Company No.
013227
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
02 Mar 1982
- Date of AGM
29 Sep 2010
- Date of Balance Sheet
31 Mar 2010
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Atlas Laboratories And Pharmaceuticals?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Salil Kapur  | Director | 10-Aug-1991 | Current |
| Suresh Gupta | Director | 30-Jul-2007 | Current |
| Pradeep Kumar | Director | 16-May-2011 | Current |
| Sumit Saini | Additional Director | 31-Aug-2018 | Current |
Financial Performance and Corporate Structure Insights of Atlas Laboratories And Pharmaceuticals.
Enhance accessibility to Atlas Laboratories And Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Atlas Laboratories And Pharmaceuticals?
Unlock access to Atlas Laboratories And Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Indian Overseas Bank Creation Date: 01 May 2008 | ₹5.00 Cr | Open |
Indian Overseas Bank Creation Date: 14 Jan 2006 | ₹20.00 Cr | Open |
Indian Overseas Bank Creation Date: 14 Jan 2006 | ₹7.00 Cr | Open |
How Many Employees Work at Atlas Laboratories And Pharmaceuticals?
Unlock and access historical data on people associated with Atlas Laboratories And Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Atlas Laboratories And Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Atlas Laboratories And Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
